Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Crowther

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
New anticoagulants: current status and future potentialJeffrey I Weitz, Mark A Crowther
Circulation|May 13, 2009
Adverse prognostic significance of thrombocytopenia in acute coronary syndrome: can anything be done about it?Theodore E Warkentin, Mark A Crowther
Seminars in Thrombosis and Hemostasis|October 29, 2008
Preventing venous thromboembolism in critically ill patientsMark A Crowther, Deborah J Cook
Current Opinion in Pulmonary Medicine|August 12, 2005
Anticoagulation therapy in the antiphospholipid syndrome: recent advancesHeng Joo Ng, Mark A Crowther
Thrombosis and Haemostasis|May 30, 2006
Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathyHeng Joo Ng, Mark A Crowther
Cleveland Clinic Journal of Medicine|June 18, 2008
Thrombotic thrombocytopenic purpura: 2008 updateMark A Crowther, James N George
Annals of Internal Medicine|January 17, 2003
Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification systemMark A Crowther, John G Kelton
Current Opinion in Critical Care|September 13, 2008
Thromboprophylaxis in medical-surgical critically ill patientsMark A Crowther, Deborah J Cook
Blood|December 25, 2010
The "age" of understanding VKA doseNeil A Goldenberg, Mark A Crowther
Thrombosis and Haemostasis|May 8, 2015
Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulantsChristopher M Hillis, Mark A Crowther
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
New anticoagulants: current status and future potentialJeffrey I Weitz, Mark A Crowther
Circulation|May 13, 2009
Adverse prognostic significance of thrombocytopenia in acute coronary syndrome: can anything be done about it?Theodore E Warkentin, Mark A Crowther
Seminars in Thrombosis and Hemostasis|October 29, 2008
Preventing venous thromboembolism in critically ill patientsMark A Crowther, Deborah J Cook
Current Opinion in Pulmonary Medicine|August 12, 2005
Anticoagulation therapy in the antiphospholipid syndrome: recent advancesHeng Joo Ng, Mark A Crowther
Thrombosis and Haemostasis|May 30, 2006
Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathyHeng Joo Ng, Mark A Crowther
Cleveland Clinic Journal of Medicine|June 18, 2008
Thrombotic thrombocytopenic purpura: 2008 updateMark A Crowther, James N George
Annals of Internal Medicine|January 17, 2003
Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification systemMark A Crowther, John G Kelton
Current Opinion in Critical Care|September 13, 2008
Thromboprophylaxis in medical-surgical critically ill patientsMark A Crowther, Deborah J Cook
Blood|December 25, 2010
The "age" of understanding VKA doseNeil A Goldenberg, Mark A Crowther
Thrombosis and Haemostasis|May 8, 2015
Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulantsChristopher M Hillis, Mark A Crowther
Pageof 24